Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
caudal-Institute of Child Health refers to a specific pharmacological combination used in clinical research conducted by the Institute of Child Health (Great Ormond Street Hospital) to study the anatomical distribution of caudal anesthesia in pediatric patients. The intervention consists of the local anesthetic **bupivacaine** (typically at a concentration of 0.175%) mixed with the non-ionic radiopaque contrast agent **iohexol** (typically 180 mg/ml). Bupivacaine acts as a sodium channel blocker, inhibiting the influx of sodium ions through voltage-gated channels in nerve cell membranes, thereby preventing the initiation and conduction of nerve impulses to provide regional anesthesia. Iohexol is included to facilitate radiological visualization of the anesthetic's spread within the epidural space via X-ray or fluoroscopy. This combination was primarily utilized in a radiological study (such as NCT00131612) to determine how different injection volumes affect the cephalad spread and clinical efficacy of caudal blocks in children aged 1 to 7 years.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupivacaine + iohexol.